These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3729334)

  • 1. Conversion of 5-fluorocytosine to 5-fluorouracil by human intestinal microflora.
    Harris BE; Manning BW; Federle TW; Diasio RB
    Antimicrob Agents Chemother; 1986 Jan; 29(1):44-8. PubMed ID: 3729334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro study on the active conversion of flucytosine to fluorouracil by microorganisms in the human intestinal microflora.
    Vermes A; Kuijper EJ; Guchelaar HJ; Dankert J
    Chemotherapy; 2003 May; 49(1-2):17-23. PubMed ID: 12714804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on deamination of 5-fluorocytosine in fungal cells.
    Pawlik B; Barylak J
    Mykosen; 1979 Sep; 22(9):328-35. PubMed ID: 530295
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase.
    Huber BE; Austin EA; Richards CA; Davis ST; Good SS
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8302-6. PubMed ID: 8058798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for conversion of 5-fluorocytosine to 5-fluorouracil in humans: possible factor in 5-fluorocytosine clinical toxicity.
    Diasio RB; Lakings DE; Bennett JE
    Antimicrob Agents Chemother; 1978 Dec; 14(6):903-8. PubMed ID: 742878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flucytosine conversion to fluorouracil in humans: does a correlation with gut flora status exist? A report of two cases using fluorine-19 magnetic resonance spectroscopy.
    Malet-Martino MC; Martino R; de Forni M; Andremont A; Hartmann O; Armand JP
    Infection; 1991; 19(3):178-80. PubMed ID: 1889873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-fluorocytosine-related bone-marrow depression and conversion to fluorouracil: a pilot study.
    Vermes A; Guchelaar HJ; van Kuilenburg AB; Dankert J
    Fundam Clin Pharmacol; 2002 Feb; 16(1):39-47. PubMed ID: 11903511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of LC-HRMS methods for evaluation of metabolic conversion of 5-fluorocytosine at GDEPT procedure.
    Skvara P; Durinikova E; Grabicová K; Mordacikova E; Matuskova M; Vojs Stanova A
    J Pharm Biomed Anal; 2021 Sep; 203():114168. PubMed ID: 34089981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of 5-fluorouracil from 5-fluorocytosine by monoclonal antibody-cytosine deaminase conjugates.
    Senter PD; Su PC; Katsuragi T; Sakai T; Cosand WL; Hellström I; Hellström KE
    Bioconjug Chem; 1991; 2(6):447-51. PubMed ID: 1805942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral generation of 5-fluorouracil mediated by an antibody-cytosine deaminase conjugate in combination with 5-fluorocytosine.
    Wallace PM; MacMaster JF; Smith VF; Kerr DE; Senter PD; Cosand WL
    Cancer Res; 1994 May; 54(10):2719-23. PubMed ID: 8168103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the mode of action of 5-fluorocytosine in Aspergillus species.
    Wagner GE; Shadomy S
    Chemotherapy; 1979; 25(2):61-9. PubMed ID: 156110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and tolerance of repeated oral administration of 5-fluorocytosine in healthy dogs.
    Béguin J; Kohlhauer M; Laloy E; Degorce F; Moreau B; Quéméneur É; Erbs P; Klonjkowski B; Maurey C
    BMC Vet Res; 2021 Jun; 17(1):220. PubMed ID: 34154593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-fluorocytosine susceptibility of pathogenic fungi in the presence of allopurinol: potential for improving the therapeutic index of 5-fluorocytosine.
    Kerkering TM; Schwartz PM; Espinel-Ingroff A; Turek PJ; Diasio RB
    Antimicrob Agents Chemother; 1983 Sep; 24(3):448-9. PubMed ID: 6639003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunosuppressive effects of 5-fluorocytosine and 5-fluorouracil.
    Berenbaum MC
    Chemotherapy; 1979; 25(1):54-9. PubMed ID: 421598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of minor metabolites of 5-fluorocytosine in man by chemical ionization gas chromatography mass spectrometry.
    Williams KM; Duffield AM; Christopher RK; Finlayson PJ
    Biomed Mass Spectrom; 1981 Apr; 8(4):179-82. PubMed ID: 7236867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sensitivity and resistance of pathogenic yeasts to 5-fluoropyrimidines. II.--Mechanisms of resistance to 5-fluorocytosine (5-FC) and 5-fluorouracil (5-FU) (author's transl)].
    Montplaisir S; Drouhet E; Mercier-Soucy L
    Ann Microbiol (Paris); 1975; 126B(1):41-9. PubMed ID: 1211721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: a potential purging method for autologous transplantation.
    Garcia-Sanchez F; Pizzorno G; Fu SQ; Nanakorn T; Krause DS; Liang J; Adams E; Leffert JJ; Yin LH; Cooperberg MR; Hanania E; Wang WL; Won JH; Peng XY; Cote R; Brown R; Burtness B; Giles R; Crystal R; Deisseroth AB
    Blood; 1998 Jul; 92(2):672-82. PubMed ID: 9657770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodality therapy with a replication-conditional herpes simplex virus 1 mutant that expresses yeast cytosine deaminase for intratumoral conversion of 5-fluorocytosine to 5-fluorouracil.
    Nakamura H; Mullen JT; Chandrasekhar S; Pawlik TM; Yoon SS; Tanabe KK
    Cancer Res; 2001 Jul; 61(14):5447-52. PubMed ID: 11454690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of action of 5-fluorocytosine.
    Waldorf AR; Polak A
    Antimicrob Agents Chemother; 1983 Jan; 23(1):79-85. PubMed ID: 6338821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor efficiency of the cytosine deaminase/5-fluorocytosine suicide gene therapy system on malignant gliomas: an in vivo study.
    Lv SQ; Zhang KB; Zhang EE; Gao FY; Yin CL; Huang CJ; He JQ; Yang H
    Med Sci Monit; 2009 Jan; 15(1):BR13-20. PubMed ID: 19114960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.